tbuckley/cabot-search huggingface dataset:
An evaluation of lifestyle changes in Turkish cancer patients after diagnosis.
Authors: Perran Fulden Yumuk, Benan Kahraman, Merve Yilmaz, Melike Koyyeri, Merve Binici, Nazim S. Turhal
Journal: Journal of Clinical Oncology (2013)

e20503 Background: To determine lifestyle changes in cancer patients after the diagnosis of malignancy. Methods: Between March 16th and September 30th, 2011, a questionnaire consisting of 20 questions was administered via a face-to-face interview to 150 patients at the Marmara University Hospital Oncology Unit. Each patient was queried during the administration of their chemotherapy. Six of the questions were independent choices, and 14 were dependent (multiple choice). A local ethical committee approval is obtained. Results: Of the 150 patients, 70 (46%) were male and 80 were female, and their median age was 55 (range 22-82) years old. An unusually large percentage (28%) of the patients reported that they did not know their diagnosis, and in another question 25% reported that they did not want to talk about their illness. Following their diagnosis, 71% of males and 50% of females reported that they were complying with guidelines for a healthy lifestyle, and 19% of the patients said that they were eating healthier food. At the time they filled out the questionnaire, 61% said that they were hopeful; however, close to 10% said that they felt hopeless. Approximately 53% of the participants said that following their diagnosis, they had a more sympathetic view of the underserved and underprivileged. Conclusions: It was surprising that an unexpectedly high percentage of the respondents reported that they did not make any changes in their lifestyles after their diagnosis of cancer, including eating healthier food. It appears Turkish cancer patients are coping with cancer in different means and ways than we expected of them.
PHYTOESTROGEN BLOOD LEVELS, MAJOR ADVERSE CARDIAC EVENTS AND ANGINA HOSPITALIZATION: A REPORT FROM THE WOMEN's ISCHEMIA SYNDROME EVALUATION
Authors: Lili Barsky, Galen Cook-Wiens, Mark Doyle, Chrisandra Shufelt, William Rogers, Carl J. Pepine, C. Noel Bairey Merz
Journal: Journal of the American College of Cardiology (2020)
3D PRINTED VALVE MODELS REPLICATE IN VIVO BICUSPID AORTIC VALVE PEAK PRESSURE DROPS
Authors: Harminder Gill, Joao F. Fernandes, Malenka Bissell, Shu Wang, Julio Sotelo, Jesus Urbina, Sergio Uribe, David Nordsletten, Saul Myerson, Kawal Rhode, Ronak Rajani, Pablo Lamata
Journal: Journal of the American College of Cardiology (2020)
Post-sepsis immunosuppression depends on NKT cell regulation of mTOR/IFN-γ in NK cells
Authors: Edy Y. Kim, Hadas Ner-Gaon, Jack Varon, Aidan M. Cullen, Jingyu Guo, Jiyoung Choi, Diana Barragan-Bradford, Angelica Higuera, Mayra Pinilla-Vera, Samuel A.P. Short, Antonio Arciniegas-Rubio, Tomoyoshi Tamura, David E. Leaf, Rebecca M. Baron, Tal Shay, Michael B. Brenner
Journal: Journal of Clinical Investigation (2020)

As treatment of the early, inflammatory phase of sepsis improves, post-sepsis immunosuppression and secondary infection have increased in importance. How early inflammation drives immunosuppression remains unclear. Although IFN-γ typically helps microbial clearance, we found that increased plasma IFN-γ in early clinical sepsis was associated with the later development of secondary Candida infection. Consistent with this observation, we found that exogenous IFN-γ suppressed macrophage phagocytosis of zymosan in vivo, and antibody blockade of IFN-γ after endotoxemia improved survival of secondary candidemia. Transcriptomic analysis of innate lymphocytes during endotoxemia suggested that NKT cells drove IFN-γ production by NK cells via mTORC1. Activation of invariant NKT (iNKT) cells with glycolipid antigen drove immunosuppression. Deletion of iNKT cells in Cd1d–/– mice or inhibition of mTOR by rapamycin reduced immunosuppression and susceptibility to secondary Candida infection. Thus, although rapamycin is typically an immunosuppressive medication, in the context of sepsis, rapamycin has the opposite effect. These results implicated an NKT cell/mTOR/IFN-γ axis in immunosuppression following endotoxemia or sepsis. In summary, in vivo iNKT cells activated mTORC1 in NK cells to produce IFN-γ, which worsened macrophage phagocytosis, clearance of secondary Candida infection, and mortality.
Molecular identification, expression and prognostic role of estrogen alpha, beta and progesteron receptors in head and neck cancer
Authors: J. Timar professor, J. Lukits, E. Rásó, M. Kásler, É. Remenár
Journal: Journal of Clinical Oncology (2006)

20056 Background: Previous data suggested hormone receptor protein expressions in head and neck cancer (HNC), but the molecular identification of the receptors was lacking and the prognostic significance was unclear. Methods: Sixty seven freshly frozen surgical samples of HNC patients were used throughout the study. Sex hormone receptor protein expression (ERa, Erb and PgR) of tumor cells was determined by immunocytochemistry. In case of positive reaction, data have been confirmed at mRNA level by nested-PCR and sequencing. Prognostic significance of the hormone receptor expression was determined by statistical analysis of the 4 year survival of the patients. Results: ER and PgR expressions confirmed by PCR analysis were frequent in HNC: 50.7 and 49.3%, respectively. Concerning the ER isoforms, ERa was predominant (41.8%) over ERb (28.4%) in both of oral as well as glottic cancers. The incidence of functional receptor expression (coexpression of ER and PgR) was relatively frequent in HNC: 41.8% which was independent of the anatomical location of the tumor. A minimum of 3 year follow up data were available for 51 HNC patients. Sex hormone receptor expressions did not affect survival, however, in the glottic cancer subgroup (n = 36) the ER expression was associated with a shortened 4 survival (23.1 versus 65.0%, respectively). Conclusions: ERa,b and PgR expression is frequent in HNC and may affect the prognosis of the disease at least in case of glottic cancer. On the other hand, the frequent coexpression of ER isoforms with PgR in HNC raises the possibility of clinical application of selective estrogen receptor modulators in this cancer type.This work is supported by the grant NKFP1a-0024–05. No significant financial relationships to disclose.
COMPARISON OF DISTAL RADIAL IN THE ANATOMICAL SNUFFBOX VERSUS CONVENTIONAL TRANSRADIAL ACCESS FOR CHRONIC TOTAL OCCLUSION PERCUTANEOUS CORONARY INTERVENTION (TWO CENTERS EXPERIENCE)
Authors: Mohamed Elbayoumi, Islam Ghanem, Mohamed Oraby, Mohamed Magdy, Mohamed Mansour, Amr Imam, Hatem Khairy, Yousry Kamel, Mohamed Ossama, Chiung-Jen Wu
Journal: Journal of the American College of Cardiology (2020)
Exhausted phenotype of follicular CD8 T cells in CVID
Authors: Adam Klocperk, Susanne Unger, David Friedmann, Maximilian Seidl, Katharina Zoldan, Jens Pfeiffer, Oliver Hausmann, Vladimir Benes, Geoffroy Andrieux, Tobias Boettler, Anna Sediva, Bertram Bengsch, Klaus Warnatz
Journal: Journal of Allergy and Clinical Immunology (2020)
INFLUENCE OF AGE ON EFFICACY AND SAFETY OF SACUBITRIL/VALSARTAN IN HEART FAILURE WITH PRESERVED EJECTION FRACTION
Authors: Orly Vardeny, Brian Claggett, Inderjit Anand, Muthiah Vaduganathan, Marc A. Pfeffer, Faiez Zannad, Aldo Pietro Maggioni, Margaret M. Redfield, Milton Packer, Akshay S. Desai, John Cleland, Gerasimos S. Filippatos, Sanjiv Shah, John McMurray, Scott D. Solomon
Journal: Journal of the American College of Cardiology (2020)
COMPARISON OF OUTCOMES IN PATIENTS UNDERGOING TRANSCATHETER AORTIC VALVE REPLACEMENT: REDUCED EJECTION FRACTION VS. MID-RANGE EJECTION FRACTION
Authors: Mohammad Al-Akchar, Abdisamad M. Ibrahim, Nitin Tandan, Hadi Mahmaljy, Mukul Bhattarai, Nilesh Goswami, Sachin Goel, Zaher Fanari
Journal: Journal of the American College of Cardiology (2020)
Comorbidity and survival in veterans with non-Hodgkin's lymphoma (NHL).
Authors: Leroy Cordero Floyd, Shanthi Srinivas, Melanie L. Gonzalez, Victor Tsu-Shih Chang, Janet Cogswell, Jan Einhorn, Maryann Sullivan, Lourdes Duque, Emma Paz-Querubin,, Monica McPherson, Barbara Crump, Basil Kasimis
Journal: Journal of Clinical Oncology (2012)

e19638 Background: Predictors of survival in patients with NHL remain an area of intense interest. Our aim was to determine whether comorbidity indices can be used to predict survival in veterans with NHL. Methods: In an IRB-approved protocol, we reviewed the records of 152 veterans diagnosed with NHL from January 1997 to December 2011 at VANJHCS. Records were reviewed for demographic, clinical and pathology data including HIV, Hep B/C, ECOG PS (PS) and Veteran status- Vietnam (V), Non-Vietnam era(non-V). PS, International Prognosis Index (IPI) and Follicular Lymphoma International Prognostic Index (FLIPI) were tabulated. Comorbidity was assessed using the Charlson Comorbidity Index (CCI), the Kaplan-Feinstein Index (KFI) and the Cumulative Illness Rating Scale (CIRS). Cox regression analysis was used to determine predictors of survival using SAS v9.2. Results: A total of 152 Veterans data were analyzed; 78 V and 74 non-V; the groups did not differ by PS, stage, beta 2 microglobulin (b2m), and HIV status, IPI/FLIPI. In univariate analysis, Grade, PS, Hgb, LDH, Alb and comorbidity indices were predictors of survival. In a multivariate analysis Grade, PS, LDH were predictors of survival in both groups. Comorbidity indices were predictors of survival only in the V group. Conclusions: Grade, PS, and LDH are predictors of survival in both groups. Comorbidity indices were able to predict survival only in the V group probably because the groups differed in age and tumor grade. Supported by New Jersey Commission Cancer Research 09-1133-CCR-EO. [Table: see text]
PREDICTORS AND OUTCOMES OF PATIENT-PROSTHESIS MISMATCH AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT: IMPACT OF AGE AND BODY MASS INDEX
Authors: Kai Chen, Marcos Nores, Taylor James, Mark Rothenberg, Arvind Kapilla, Cristiano Faber, Lawrence Lovitz, Sotiris Stamou
Journal: Journal of the American College of Cardiology (2020)
ASSOCIATION BETWEEN LIPOPROTEIN (A) WITH AORTIC VALVE CALCIUM IN SOUTH ASIANS AND COMPARISON TO OTHER RACE/ETHNIC GROUPS
Authors: Minhal Makshood, Parag Joshi, Alka Kanaya, Colby Ayers, Matthew J. Budoff, Michael Tsai, Michael Blaha, Erin Michos, Wendy S. Post
Journal: Journal of the American College of Cardiology (2020)
P2Y12 INHIBITOR USE AND DISCONTINUATION PRIOR TO CABG IN PATIENTS WITH LEFT MAIN DISEASE: ANALYSIS FROM THE EXCEL TRIAL
Authors: Mahesh Madhavan, Christopher R. Kelly, Joseph Sabik, W. Morris Brown, Ferenc Horkay, Piet W. Boonstra, Gábor Bogáts, Nicolas Noiseux, Yiran Zhang, Patrick Serruys, A. Kappetein, Gregg Stone
Journal: Journal of the American College of Cardiology (2020)
IMPACT OF RESIDUAL MITRAL REGURGITATION ON MORTALITY AFTER ACUTE SUCCESSFUL MITRACLIP IMPLANTATION: A SYSTEMATIC REVIEW AND META-ANALYSIS
Authors: Chol Techorueangwiwat, Chanavuth Kanitsoraphan, Pattara Rattanawong, Jakrin Kewcharoen
Journal: Journal of the American College of Cardiology (2020)
ASSOCIATION BETWEEN SHORT-TERM HEALTH STATUS CHANGES AND LONG-TERM CLINICAL OUTCOMES AFTER TRANSCATHETER MITRAL VALVE REPAIR VS. MEDICAL THERAPY IN PATIENTS WITH HEART FAILURE AND FUNCTIONAL MITRAL REGURGITATION: THE COAPT TRIAL
Authors: Suzanne V. Arnold, Gregg W. Stone, Michael Mack, Adnan Chhatriwalla, Bethany Austin, Zixuan Zhang, Ori Ben-Yehuda, Saibal Kar, None Kar, Scott Lim, JoAnn Lindenfeld, William Abraham, David J. Cohen
Journal: Journal of the American College of Cardiology (2020)
NON ATHEROSCLEROTIC SPONTANEOUS CORONARY ARTERY DISSECTION OF THE RIGHT CORONARY ARTERY IN EVOLUTION - WAS NORETHINDRONE THE CULPRIT
Authors: Yuvraj Chowdhury, Ricardo Castillo, Hal Chadow, Mark Russell, Pramod Theetha Kariyanna, Danny Russell, Qabbani Hope, Abhishek Chakraborty, Mrinali Shetty
Journal: Journal of the American College of Cardiology (2020)
USE OF SHORT- VERSUS LONG-ACTING DIURETICS AND ITS ASSOCIATION WITH LONG-TERM OUTCOMES AFTER DISCHARGE IN PATIENTS HOSPITALIZED FOR ACUTE HEART FAILURE
Authors: Shohei Imaeda, Yasuyuki Shiraishi, Nozomi Niimi, Ayumi Goda, Takashi Kohno, Yuji Nagatomo, Yosuke Nishihata, Mike Saji, Shun Kohsaka, Tsutomu Yoshikawa
Journal: Journal of the American College of Cardiology (2020)
Correlation of epidermal growth factor receptor (EGFR) mutation, immunohistochemistry (IHC), and fluorescence in situ hybridization (FISH) in esophageal squamous cell carcinoma (ESCC)
Authors: P. Sunpaweravong, S. Suwiwat, S. Sunpaweravong, P. Puttawibul, M. Varella-Garcia, W. Mitarnun
Journal: Journal of Clinical Oncology (2006)

4085 Background: ESCC remains a devastating cancer in Southern Thailand and novel therapeutic approach needs to be explored. EGFR tyrosine kinase (TK) inhibitor is a potential therapeutic agent against EGFR-expression tumors including ESCC. Forty-nine percent of ESCC patients in our institution overexpressed EGFR protein and 15% had EGFR gene amplification as published previously. Mutations within EGFR TK domain, particularly in exon 19 and 21, EGFR amplification or polysomy, and EGFR overexpression on IHC have all been associated with sensitivity and benefit to EGFR inhibitor treatment. To our best knowledge, no data on EGFR mutations in ESCC have been reported. This prompted us to perform analysis of EGFR mutations and correlate the status of each of these characteristics in ESCC. Methods: We studied 35 patients with ESCC whose data on EGFR IHC and FISH were available. DNA extraction was performed using a QIAamp DNA Kit. PCR for EGFR detection, using the oligonucleotide primers for amplification of exon 19 and 21, was sequenced and analyzed, using ABI Prism 377 sequencing analysis system and the Big Dye Terminator V3.0 Ready Reaction Cycle Sequencing Kit (ABI Prism). Results: Among 35 ESCC specimens evaluated, no EGFR somatic mutations in exon 19 or 21 were detected. Conclusions: EGFR mutations in exon 19 and 21 of ESCC were not identified in this study. EGFR overexpression and amplification do not correlate with EGFR mutation in Thai patients with ESCC. A clinical study of an EGFR inhibitor in esophageal carcinoma has been going on in our institution and the molecular markers as predictive factors need to be further evaluated and correlated with treatment outcome. No significant financial relationships to disclose.
NK cells mediate clearance of CD8 <sup>+</sup> T cell–resistant tumors in response to STING agonists
Authors: Christopher J. Nicolai, Natalie Wolf, I-Chang Chang, Georgia Kirn, Assaf Marcus, Chudi O. Ndubaku, Sarah M. McWhirter, David H. Raulet
Journal: Science Immunology (2020)

STING agonists trigger NK cell–mediated clearance of MHC-deficient tumors resistant to CD8 + T cells and NK-sensitive, MHC-expressing tumors.
Esophageal type 2 cytokine expression heterogeneity in eosinophilic esophagitis in a multisite cohort
Authors: Julia L.M. Dunn, Tetsuo Shoda, Julie M. Caldwell, Ting Wen, Seema S. Aceves, Margaret H. Collins, Evan S. Dellon, Gary W. Falk, John Leung, Lisa J. Martin, Paul Menard-Katcher, Amanda K. Rudman-Spergel, Jonathan M. Spergel, Joshua B. Wechsler, Guang-Yu Yang, Glenn T. Furuta, Marc E. Rothenberg
Journal: Journal of Allergy and Clinical Immunology (2020)
SUPRA-ANNULAR PLACEMENT OF BALLOON EXPANDABLE TRANSCATHETER AORTIC VALVE IN SURGICAL VALVE AND SUBSEQUENT FRACTURING OF SURGICAL ANNULUS TO ACHIEVE IDEAL HEMODYNAMICS: A NOVEL TECHNIQUE
Authors: Salik Nazir, Ahmed Elzanaty, John Letcher, Michael Moront, P. Kasi Ramanathan
Journal: Journal of the American College of Cardiology (2020)
IS A NORMAL BODY MASS INDEX PROTECTIVE IN WOMEN WITH METABOLIC SYNDROME AND SUSPECTED MYOCARDIAL ISCHEMIA?
Authors: Odayme Quesada, Janet Wei, Nissi Suppogu, Galen Cook-Wiens, Marie Lauzon, Leslee J. Shaw, William Rogers, Eileen Handberg, Carl J. Pepine, C. Noel Bairey Merz
Journal: Journal of the American College of Cardiology (2020)
Nasal allergen challenge and environmental exposure chamber challenge: A randomized trial comparing clinical and biological responses to cat allergen
Authors: David Larson, Piyush Patel, Anne Marie Salapatek, Peter Couroux, Don Whitehouse, Adela Pina, Jacqueline L. Johnson, Michelle L. Sever, Srinath Sanda, Julian Poyser, Theresa Allio, Guy W. Scadding, Tielin Qin, Mohamed H. Shamji, William W. Kwok, Eddie A. James, Deanna French, Alina Lelic, Mark Larché, Matthew C. Altman, Alkis Togias, Stephen R. Durham
Journal: Journal of Allergy and Clinical Immunology (2020)
More awareness is needed for severe acute respiratory syndrome coronavirus 2019 transmission through exhaled air during non-invasive respiratory support: experience from China
Authors: Lili Guan, Luqian Zhou, Jinnong Zhang, Wei Peng, Rongchang Chen
Journal: European Respiratory Journal (2020)

As of 17 February, 2020, China has 70 635 confirmed cases of coronavirus disease 2019 (COVID-19), including 1772 deaths [1]. Human-to-human spread of the virus via respiratory droplets is currently considered to be the main route of transmission. However, exhaled air dispersion during non-invasive respiratory support may increase the risk of coronavirus transmission, and requires more attention from medical personnel and patients. Non-invasive respiratory support plays an essential role in the treatment of COVID-19. More awareness is needed of viral transmission through exhaled air. <http://bit.ly/39kNrrF>
The outcome of infant ALL: Experience at King Abdulaziz Medical City, Jeddah, western Region of Kingdom of Saudi Arabia
Authors: T. M. Khattab, S. K. Felimban, A. Atra
Journal: Journal of Clinical Oncology (2006)

9038 Background: Infants with ALL have a worse prognosis than older children. Several regimens has been used with a 4 years event free survival ranging from 25%-40%. An international collaborative treatment protocol (Interfant 99) based on the understanding of the biology of infant ALL was introduced aiming to improve the outcome and study the role of allogeneic bone marrow transplantation (BMT). To review the clinical features, treatment outcome and causes of treatment failure of all infant ALL treated at our center. Methods: We retrospectively reviewed all case notes of children with ALL diagnosed between 1986–2005 to identify infants &lt;12 months with ALL. The age, WBC and CNS disease at diagnosis were reviewed. Treatment details and survival were studied. Results: Among 351 patients with ALL, 12 were infants (4.2%). Patients charachteristics are shown in table below. Six were boys and 6 were &lt; 6 month at diagnosis. Nine patients (75%) had WBC count &gt;100,000 and 4/12 CNS disease at presentation. Immunophenotyping showing lacking CD10 7/12, biphentyping 3/12, unknown 2/12 and t (4:11) found in 2/12. Treatment consisted of UKALL-based in 7 patients and Interfant 99 protocol in 5. Two patients received BMT, one from unrelated donor and the other with one antigen mismatch from his mother. Six patients (50%) died of toxicity and 3(25%) of recurrent leukemia including one who had unrelated donor BMT. Three patients survive in full remission including one who had BMT from his mother. Conclusions: This small single center study confirms the inferior outcome of infant ALL. Toxic death remains a major cause of treatment failure. Because of the rarity of infant ALL, international collaboration is required to study the role of different chemotherapy regimens and assess the role of allogeneic BMT. [Table: see text] No significant financial relationships to disclose.
ACUTE EFFECTS OF PHOSPHODIESTERASE-5 INHIBITION ON RIGHT VENTRICULAR FUNCTION IN ADVANCED HFREF: THE INSIGHT FROM PRESSURE-VOLUME ANALYSIS
Authors: Vojtech Melenovsky, Luca Monzo, Hikmet Al-Hiti, Adrian Reichenbach, Tereza Havlenova, Nevenka Solar, Marek Tupy, Jiri Ters, Josef Kautzner
Journal: Journal of the American College of Cardiology (2020)
ASSESSING THE SAFETY AND CLINICAL OUTCOMES OF BETA-BLOCKERS IN PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION WITH CONCOMITANT COCAINE USE: A META-ANALYSIS
Authors: Kirtipal Bhatia, Vivek Amit Modi, Bharat Narasimhan, Aditya A. Joshi, Karan Sud, Lingling Wu, Guneesh Uberoi, Devika Aggarwal, Celine Soudant, Syed Haider, Arieh Fox
Journal: Journal of the American College of Cardiology (2020)
Effects of angiotensin-converting enzyme (ACE) inhibitors on the outcomes of patients receiving primary radiotherapy for prostate cancer (PC).
Authors: Weranja Kalana Bodhisiri Ranasinghe, Scott G. Williams, Shomik Sengupta, Mike Chang, Arthur Shulkes, Damien M. Bolton, Graham Baldwin, Oneel Patel
Journal: Journal of Clinical Oncology (2013)

e16016 Background: ACE inhibitors have been linked with an increased incidence of prostate, breast and lung cancer as well as increased recurrence rates in breast cancer. However the effects of ACE inhibitors on patients receiving primary radiation therapy for PC are unknown. Methods: We conducted a retrospective medication review of a prospective cohort of 1956 men who received primary radiotherapy (RT) for PC at the Peter McCallum Cancer Institute, Melbourne, Australia from 2003 -07. A competing risks model was developed for statistical analysis of the data. Results: 56% of patients who received RT also had concurrent salvage androgen deprivation therapy (sADT). A total 502 men had subsequent biochemical failure, 314 had initiated sADT and 125 had died of prostate cancer. Median follow up after RT was 71 months and 41 months after initiation of sADT. Of the 603 men who were on ACE-inhibitors, 160 received sADT. After adjusting for patient age, initial tumor stage, Gleason Score and PSA, along with planned ADT usage and ACE27 co-morbidity score, there were significant association between ACE-inhibitors and PC-specific mortality both from the time of RT and sADT (p= 0.035 and 0.01 respectively), with a strong increase in hazard (HR 1.58 [95%CI 1.03-2.42) and 2.02 [95%CI 1.16-2.90]). No significant association was seen with time to metastasis development, suggesting the impact of ACE inhibitors may be in the post-metastasis phase of the disease. Conclusions: ACE inhibitors may increase the rates of PC-specific mortality in men receiving primary RT for PC. However these results need to be further validated by randomized controlled studies and the mechanisms need to be investigated.
AN INFLAMMATORY PSEUDOTUMOR INFILTRATING THE MITRAL VALVE AND THE LEFT VENTRICULAR WALL
Authors: Hibiki Mima, Yodo Tamaki, Hamguchi Yukihiro, Maki Hamsaki, Kojima Hidenori, Yamasaki Seita, Okamoto Hiroki, Tamura Akinori, Yuki Obayashi, Kuroda Maiko, Harita Takeshi, Nishiuchi Suguru, Sakamoto Jiro, Enomoto Soichiro, Makoto Miyake, Hirokazu Kondo, Toshihiro Tamura
Journal: Journal of the American College of Cardiology (2020)